Risk of natalizumab-associated progressive multifocal leukoencephalopathy.
暂无分享,去创建一个
Meena Subramanyam | A. Sandrock | C. Hotermans | S. Goelz | M. Subramanyam | T. Plavina | G. Bloomgren | S. Richman | Sophia Lee | C. Bozic | Tatiana Plavina | Alfred Sandrock | Gary Bloomgren | Sandra Richman | Christophe Hotermans | Susan Goelz | Amy Natarajan | Sophia Lee | James V Scanlon | Carmen Bozic | A. Natarajan | J. Scanlon
[1] G. Lichtenstein. Progressive Multifocal Leukoencephalopathy After Natalizumab Therapy for Crohn's Disease , 2006 .
[2] K. Simon,et al. Anti‐JC virus antibodies: Implications for PML Risk Stratification , 2010, Annals of neurology.
[3] A. Verma. Progressive Multifocal Leukoencephalopathy in a Patient Treated With Natalizumab , 2006 .
[4] E. Major. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. , 2010, Annual review of medicine.
[5] I. Koralnik,et al. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis , 2010, The Lancet Neurology.
[6] D. Clifford,et al. Natalizumab-associated progressive multifocal leukoencephalopathy. , 2012 .
[7] Ludwig Kappos,et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. , 2006, The New England journal of medicine.
[8] J. F. Foley,et al. Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy , 2011, Neurology.
[9] F. Barkhof,et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. , 2006, The New England journal of medicine.
[10] K. Tyler,et al. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. , 2005, The New England journal of medicine.
[11] A. Sandrock,et al. Anti‐John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY‐1 , 2011, Annals of neurology.
[12] Adrian Egli,et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. , 2009, The Journal of infectious diseases.
[13] H. Hartung,et al. [Risk stratification of progressive multifocal leukoencephalopathy under natalizumab: recommendations for JC virus serology]. , 2011, Der Nervenarzt.